| Circulating miRNA biomarkers for Alzheimer's disease P Kumar, Z Dezso, C MacKenzie, J Oestreicher, S Agoulnik, M Byrne, ... PloS one 8 (7), e69807, 2013 | 398 | 2013 |
| Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology Y Sato, I Suzuki, T Nakamura, F Bernier, K Aoshima, Y Oda Journal of lipid research 53 (3), 567-576, 2012 | 182 | 2012 |
| Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome T Maekawa, F Bernier, M Sato, S Nomura, M Singh, Y Inoue, T Tokunaga, ... Journal of Biological Chemistry 274 (25), 17813-17819, 1999 | 143 | 1999 |
| Probiotic Bifidobacterium breve in improving cognitive functions of older adults with suspected mild cognitive impairment: a randomized, double-blind, placebo-controlled trial J Xiao, N Katsumata, F Bernier, K Ohno, Y Yamauchi, T Odamaki, ... Journal of Alzheimer's Disease 77 (1), 139-147, 2020 | 117 | 2020 |
| Germin isoforms are discrete temporal markers of wheat development: Pseudogermin is a uniquely thermostable water‐soluble oligomeric protein in ungerminated embryos and like … BG Lane, AC Cuming, J Frégeau, NC Carpita, WJ Hurkman, F Bernier, ... European journal of biochemistry 209 (3), 961-969, 1992 | 93 | 1992 |
| Estrogen induces a rapid increase of calcium-calmodulin-dependent protein kinase II activity in the hippocampus T Sawai, F Bernier, T Fukushima, T Hashimoto, H Ogura, Y Nishizawa Brain research 950 (1-2), 308-311, 2002 | 91 | 2002 |
| Effect of probiotic Bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: results of a … D Asaoka, J Xiao, T Takeda, N Yanagisawa, T Yamazaki, Y Matsubara, ... Journal of Alzheimer's Disease 88 (1), 75-95, 2022 | 43 | 2022 |
| Targeting infectious agents as a therapeutic strategy in Alzheimer’s disease T Fülöp, U Munawara, A Larbi, M Desroches, S Rodrigues, M Catanzaro, ... CNS drugs 34, 673-695, 2020 | 32 | 2020 |
| P4–411: clinical study of E2609, a novel BACE1 inhibitor, demonstrates target engagement and inhibition of BACE1 activity in CSF F Bernier, Y Sato, M Matijevic, H Desmond, S McGrath, L Burns, ... Alzheimer's & Dementia 9, P886-P886, 2013 | 26 | 2013 |
| Comparative lipidomics of mouse brain exposed to enriched environment [S] Y Sato, F Bernier, I Suzuki, S Kotani, M Nakagawa, Y Oda Journal of Lipid Research 54 (10), 2687-2696, 2013 | 17 | 2013 |
| Targeting impaired antimicrobial immunity in the brain for the treatment of Alzheimer’s disease T Fulop, S Tripathi, S Rodrigues, M Desroches, T Bunt, A Eiser, F Bernier, ... Neuropsychiatric Disease and Treatment, 1311-1339, 2021 | 16 | 2021 |
| Reduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease Y Sato, F Bernier, Y Yamanaka, K Aoshima, Y Oda, M Ingelsson, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (1), 67-74, 2015 | 12 | 2015 |
| Association of plasma hemoglobin A1c with improvement of cognitive functions by probiotic Bifidobacterium breve supplementation in healthy adults with mild cognitive impairment F Bernier, K Ohno, N Katsumata, T Shimizu, J Xiao Journal of Alzheimer's Disease 81 (2), 493-497, 2021 | 9 | 2021 |
| P4–163: a single dose of the beta-secretase inhibitor, e2609, decreases CSF bace1 enzymatic activity in cynomolgus monkeys M Matijevic, H Watanabe, Y Sato, F Bernier, S McGrath, L Burns, ... Alzheimers Dement 11, P841, 2015 | 8 | 2015 |
| Olfactory function evaluation in a 1102 community-dwelling 20-90-year old Japanese population in relation with age, sex and mental decline M Yanagimachi, I Takahashi, F Bernier, K Takahashi, S Kurauchi, ... Alzheimers Dement Cogn Neurol 1 (3), 1-5, 2017 | 7 | 2017 |
| Recent progress in the identification of non-invasive biomarkers to support the diagnosis of alzheimer’s disease in clinical practice and to assist human clinical trials F Bernier, P Kumar, Y Sato, Y Oda Alzheimer’s Disease: Challenges for the Future 225, 2015, 2015 | 6 | 2015 |
| Altered activity of peroxidase and oxalate oxidase influences lignification in transgenic tobacco E Burbridge, S Kjærsgaard Rasmussen, F Bernier, B Kaare Kristensen, ... The Open Plant Science Journal, 2014, 8, 1-8 8, 1-8, 2014 | 3 | 2014 |
| Plasma membranes from Physarum polycephalum Plasmodia: purification, characterization, and comparison with amoebae plasma membranes D Pallotta, A Barden, R Martel, J Kirouac-Brunet, F Bernier, A Lord, ... Canadian journal of biochemistry and cell biology 62 (9), 831-836, 1984 | 3 | 1984 |
| Biomarker for alzheimer's disease or mild cognitive impairment Y Sato, K Aoshima, F Bernier US Patent 9,581,604, 2017 | 2 | 2017 |
| Anti‐inflammation as one of the mechanisms in the improvement of cognitive function by probiotic Bifidobacterium breve strain K Ohno, F Bernier, N Katsumata, T Shimizu, JZ Xiao Alzheimer's & Dementia 17, e051966, 2021 | 1 | 2021 |
